These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 37734479)
21. A molecular mechanism for IL-4 suppression of loricrin transcription in epidermal keratinocytes: implication for atopic dermatitis pathogenesis. Bao L; Mohan GC; Alexander JB; Doo C; Shen K; Bao J; Chan LS Innate Immun; 2017 Nov; 23(8):641-647. PubMed ID: 28952836 [TBL] [Abstract][Full Text] [Related]
22. Glyteer, Soybean Tar, Impairs IL-4/Stat6 Signaling in Murine Bone Marrow-Derived Dendritic Cells: The Basis of Its Therapeutic Effect on Atopic Dermatitis. Takemura M; Nakahara T; Hashimoto-Hachiya A; Furue M; Tsuji G Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29649105 [TBL] [Abstract][Full Text] [Related]
23. Antagonistic Effects of IL-4 on IL-17A-Mediated Enhancement of Epidermal Tight Junction Function. Brewer MG; Yoshida T; Kuo FI; Fridy S; Beck LA; De Benedetto A Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31438472 [TBL] [Abstract][Full Text] [Related]
24. Potential Therapeutic Skin Microbiomes Suppressing Lee E; Min K; Ahn H; Jeon BN; Park S; Yun C; Jeon H; Yeon JS; Kim H; Park H Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076953 [TBL] [Abstract][Full Text] [Related]
25. The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling. Amano W; Nakajima S; Kunugi H; Numata Y; Kitoh A; Egawa G; Dainichi T; Honda T; Otsuka A; Kimoto Y; Yamamoto Y; Tanimoto A; Matsushita M; Miyachi Y; Kabashima K J Allergy Clin Immunol; 2015 Sep; 136(3):667-677.e7. PubMed ID: 26115905 [TBL] [Abstract][Full Text] [Related]
26. Igalan from Inula helenium (L.) suppresses the atopic dermatitis-like response in stimulated HaCaT keratinocytes via JAK/STAT3 signaling. Dao TTP; Song K; Kim JY; Kim YS Inflamm Res; 2020 Mar; 69(3):309-319. PubMed ID: 32002586 [TBL] [Abstract][Full Text] [Related]
27. Aryl hydrocarbon receptor expression in serum, peripheral blood mononuclear cells, and skin lesions of patients with atopic dermatitis and its correlation with disease severity. Hu YQ; Liu P; Mu ZL; Zhang JZ Chin Med J (Engl); 2020 Jan; 133(2):148-153. PubMed ID: 31868801 [TBL] [Abstract][Full Text] [Related]
28. Benzopyrene, a major polyaromatic hydrocarbon in smoke fume, mobilizes Langerhans cells and polarizes Th2/17 responses in epicutaneous protein sensitization through the aryl hydrocarbon receptor. Hong CH; Lee CH; Yu HS; Huang SK Int Immunopharmacol; 2016 Jul; 36():111-117. PubMed ID: 27129092 [TBL] [Abstract][Full Text] [Related]
29. Scratching damages tight junctions through the Akt-claudin 1 axis in atopic dermatitis. Hu XQ; Tang Y; Ju Y; Zhang XY; Yan JJ; Wang CM; Yang Y; Zhu C; Tang ZX; Zhou Y; Yu G Clin Exp Dermatol; 2021 Jan; 46(1):74-81. PubMed ID: 32668051 [TBL] [Abstract][Full Text] [Related]
30. Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17. Yuki T; Tobiishi M; Kusaka-Kikushima A; Ota Y; Tokura Y PLoS One; 2016; 11(9):e0161759. PubMed ID: 27588419 [TBL] [Abstract][Full Text] [Related]
31. Increased IL-26 Expression Promotes T Helper Type 17- and T Helper Type 2-Associated Cytokine Production by Keratinocytes in Atopic Dermatitis. Kamijo H; Miyagaki T; Hayashi Y; Akatsuka T; Watanabe-Otobe S; Oka T; Shishido-Takahashi N; Suga H; Sugaya M; Sato S J Invest Dermatol; 2020 Mar; 140(3):636-644.e2. PubMed ID: 31465744 [TBL] [Abstract][Full Text] [Related]
32. Lipid abnormalities in atopic skin are driven by type 2 cytokines. Berdyshev E; Goleva E; Bronova I; Dyjack N; Rios C; Jung J; Taylor P; Jeong M; Hall CF; Richers BN; Norquest KA; Zheng T; Seibold MA; Leung DY JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467325 [TBL] [Abstract][Full Text] [Related]
33. Yu-Ping-Feng-San ameliorates recurrent allergic inflammation of atopic dermatitis by repairing tight junction defects of the epithelial barrier. Zheng J; Wang X; Tao Y; Wang Y; Yu X; Liu H; Ji L; Bao K; Wang C; Jia Z; Hong M Phytomedicine; 2019 Feb; 54():214-223. PubMed ID: 30668371 [TBL] [Abstract][Full Text] [Related]
34. Lagerstroemia macrocarpa extract inhibits Th2-mediated STAT6 signaling pathway in human keratinocytes. Seo G; Hyun H; Jeong M; Park Y; Cho J; Win TTM; Win TZ; Paik J; Arbianto AD; Kim JH; Ahn J; Kim D Fitoterapia; 2024 Apr; 174():105859. PubMed ID: 38354819 [TBL] [Abstract][Full Text] [Related]
35. The Expression and Regulation of Interleukin-33 in Human Epidermal Keratinocytes: A New Mediator of Atopic Dermatitis and Its Possible Signaling Pathway. Du HY; Fu HY; Li DN; Qiao Y; Wang QW; Liu W J Interferon Cytokine Res; 2016 Sep; 36(9):552-62. PubMed ID: 27348082 [TBL] [Abstract][Full Text] [Related]
36. Th2 cytokines increase Staphylococcus aureus alpha toxin-induced keratinocyte death through the signal transducer and activator of transcription 6 (STAT6). Brauweiler AM; Goleva E; Leung DYM J Invest Dermatol; 2014 Aug; 134(8):2114-2121. PubMed ID: 24468745 [TBL] [Abstract][Full Text] [Related]
37. Cultivated ginseng inhibits 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice and TNF-α/IFN-γ-induced TARC activation in HaCaT cells. Choi JH; Jin SW; Park BH; Kim HG; Khanal T; Han HJ; Hwang YP; Choi JM; Chung YC; Hwang SK; Jeong TC; Jeong HG Food Chem Toxicol; 2013 Jun; 56():195-203. PubMed ID: 23454147 [TBL] [Abstract][Full Text] [Related]
38. ARNT controls the expression of epidermal differentiation genes through HDAC- and EGFR-dependent pathways. Robertson ED; Weir L; Romanowska M; Leigh IM; Panteleyev AA J Cell Sci; 2012 Jul; 125(Pt 14):3320-32. PubMed ID: 22505606 [TBL] [Abstract][Full Text] [Related]
39. Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis. van den Bogaard EH; Bergboer JG; Vonk-Bergers M; van Vlijmen-Willems IM; Hato SV; van der Valk PG; Schröder JM; Joosten I; Zeeuwen PL; Schalkwijk J J Clin Invest; 2013 Feb; 123(2):917-27. PubMed ID: 23348739 [TBL] [Abstract][Full Text] [Related]
40. Experimental and Clinical Evidence Suggests That Treatment with Betacellulin Can Alleviate Th2-Type Cytokine-Mediated Impairment of Skin Barrier Function. Peng G; Tsukamoto S; Umehara Y; Kishi R; Tominaga M; Takamori K; Okumura K; Ogawa H; Ikeda S; Niyonsaba F Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232814 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]